Adults and children are prescribed as detoxification therapy when: acute poisoning of various origins (strong and poisonous substances, drugs and alcohol, alkaloids, heavy metal salts); intoxication of various origins acute intestinal infections of any origin (toxicoinfection, salmonellosis, dysentery, dysbacteriosis); purulent-septic diseases; Allergy, atopic dermatitis, urticaria eczema; viral hepatitis A and B, toxic hepatitis, liver cirrhosis, hepatocholecystitis; glomerulonephritis, pyelonephritis, polycystic kidney disease; malignant diseases (for detoxification before and after surgery, during radiation or chemotherapy).
Enterosgel Extracaps Composition
active substance: polymethylsiloxane xerogel;
1 capsule contains 0.32 g of polymethylsiloxane xerogel;
Enterosgel Extracaps excipients: gelatin, titanium dioxide (E 171).
Enterosgel Extracaps Dosage form
Basic physical and chemical properties: hard gelatin capsules, white body and lid. The contents of the capsules are white or almost white powder, odorless.
Enterosorbents. ATX code А07В С
When used internally, it has a detoxifying effect. The drug effectively adsorbs medium-molecular toxic substances, products of incomplete metabolism, from the contents of the intestine and blood (through the capillary membranes of the villi of the intestinal mucosa), promotes the elimination of incorporated radionuclides. Enterosgel ExtraCaps eliminates the manifestations of toxicosis, improves the function of the intestines, liver, kidneys, and normalizes blood and urine parameters. As an effective detoxifier, Enterosgel ExtraCaps enhances immunity.
The drug envelops the mucous membrane of the stomach and intestines, protects it from erosive processes. Not absorbed from the intestines.
As part of complex detoxification therapy for chronic renal failure, which is caused by pyelonephritis, polycystic kidney disease, nephrolithiasis; with toxic hepatitis, viral hepatitis A and B, hepatocholecystitis, liver cirrhosis and cholestasis of various etiologies, gastritis with low acidity, enterocolitis, colitis, diarrhea; in case of poisoning with alcohol and drugs; allergic reactions, skin diseases (diathesis, neurodermatitis); with burn intoxication; purulent-septic processes, which are accompanied by intoxication; toxicosis of pregnant women in the first half of pregnancy, in the complex therapy of intestinal dysbiosis.
Acute intestinal obstruction.
Individual intolerance to the components of the drug.
Interaction with other medicinal products and other forms of interaction
Subject to the method of application (Enterosgel ExtraCaps and drugs are taken separately), the drug can be used in complex therapy with other drugs and prophylactic agents, including bacterial drugs (bifidum-, lactobacilli), phytopreparations, adaptogens, immunomodulators. Concomitant use with drugs belonging to the class of bile acid sequestrants, such as cholestyramine, is not recommended due to the increased likelihood of constipation.
The drug should not be used in conjunction with silver preparations.
The drug should be taken in accordance with the recommendations set out in this leaflet.
Application during pregnancy or lactation.
The drug is used during pregnancy or lactation. Use should be limited in pregnant women prone to constipation.
The ability to influence the reaction rate when driving vehicles or other mechanisms.
Does not affect.